Published in J Med Genet on September 01, 1989
The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet (1994) 4.12
Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy. BMJ (1990) 1.72
Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur J Hum Genet (2013) 1.20
Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening. J Med Genet (1989) 1.02
PEDIG--a computer program for calculation of genotype probabilities using phenotype information. Clin Genet (1972) 3.35
Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Arch Dis Child (1979) 1.43
Implications of diagnostic delay in Duchenne muscular dystrophy. Br Med J (Clin Res Ed) (1983) 1.23
Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening. J Med Genet (1989) 1.02
Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57
Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92
Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85
Childhood accidents--an endemic of epidemic proportion. Arch Dis Child (1981) 5.81
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70
Child-resistant packaging and accidental child poisoning. Lancet (1977) 5.63
Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain (1988) 4.69
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42
E2f3 is critical for normal cellular proliferation. Genes Dev (2000) 3.26
Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18
How long do we need to observe head injuries in hospital? Arch Dis Child (1984) 3.05
Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child (1987) 2.95
Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
The prevention of Huntington's chorea. The Milroy lecture 1985. J R Coll Physicians Lond (1986) 2.74
Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65
Epidemiology of Munchausen syndrome by proxy, non-accidental poisoning, and non-accidental suffocation. Arch Dis Child (1996) 2.59
A four week study of accidents to children in South Glamorgan. Public Health (1978) 2.57
Patterns of injuries to children on public playgrounds. Arch Dis Child (1994) 2.53
The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45
Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42
Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor. Lancet (1972) 2.40
Unstable DNA sequence in myotonic dystrophy. Lancet (1992) 2.36
Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31
Drowning and near drowning in children in the United Kingdom: lessons for prevention. BMJ (1992) 2.23
E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell (2000) 2.21
The Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. Am J Psychiatry (2001) 2.19
Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18
Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet (1983) 2.16
Outcome in children who nearly drown: a British Isles study. BMJ (1991) 2.15
Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet (1993) 2.15
Why do women attend familial breast cancer clinics? J Med Genet (2000) 2.13
Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet (1987) 2.09
Adoption and genetic prediction for Huntington's disease. Lancet (1988) 2.09
Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest (2000) 2.08
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
Bicycle injuries in children. Br Med J (1977) 2.07
Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05
Linkage disequilibrium in Huntington's disease: an improved localisation for the gene. J Med Genet (1989) 2.05
Congenital myotonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child (1975) 2.04
Epilepsy in children and the risk of drowning. Arch Dis Child (1993) 2.04
Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02
Problems in genetic prediction for Huntington's disease. Lancet (1989) 2.00
Cardiac disease in myotonic dystrophy. Cardiovasc Res (1997) 1.98
Poisoning in children. Br Med J (1973) 1.94
George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet Gynecol (1971) 1.93
Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92
Objective birth data and the prediction of child abuse. Arch Dis Child (1981) 1.91
The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer (2002) 1.88
A new DNA marker tightly linked to the fragile X locus (FRAXA). Science (1989) 1.88
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet (1989) 1.87
Huntington's chorea. The basis for long-term prevention. Lancet (1979) 1.87
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
Genetic linkage confirmed between the locus for myotonic dystrophy and the ABH-secretion and Lutheran blood group loci. Am J Hum Genet (1972) 1.82
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol (2000) 1.79
Factors influencing age at onset and duration of survival in Huntington's chorea. Ann Hum Genet (1981) 1.79
Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78
Physiological and behavioural thermoregulation in bigeye tuna (Thunnus obesus). Nature (1992) 1.76
Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet (1984) 1.74
Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy. BMJ (1990) 1.72
Congenital myotonic dystrophy in Britain. II. Genetic basis. Arch Dis Child (1975) 1.71
What do hospices do? A survey of hospices in the United Kingdom and Republic of Ireland. BMJ (1990) 1.70
Huntington disease: no evidence for locus heterogeneity. Genomics (1989) 1.70
Does health education prevent childhood accidents? Postgrad Med J (1984) 1.69
Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea. J Med Genet (1983) 1.67
A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms. J Med Genet (1982) 1.66
Plasma osmolality, sodium, and urea in healthy breast-fed and bottle-fed infants in Newcastle upon Tyne. Arch Dis Child (1975) 1.66
Improvements in child resistant containers. Arch Dis Child (1985) 1.65
A scoring system for bruise patterns: a tool for identifying abuse. Arch Dis Child (2002) 1.65
Decline in the predicted incidence of Huntington's chorea associated with systematic genetic counselling and family support. Lancet (1981) 1.64
Subdural haemorrhages in infants: population based study. BMJ (1998) 1.64
Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am J Hum Genet (1991) 1.64
Evidence from family studies that the gene causing Huntington disease is telomeric to D4S95 and D4S90. Am J Hum Genet (1989) 1.64
Sudden death in individuals in hobble restraints during paramedic transport. Ann Emerg Med (1995) 1.62
Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet (1999) 1.59
A genetic register for Huntington's chorea in South Wales. J Med Genet (1982) 1.56
Farm accidents in children. BMJ (1992) 1.56
Phosphate enemas in childhood: cause for concern. BMJ (1991) 1.55
Localization of a human Na+,K+-ATPase alpha subunit gene to chromosome 19q12----q13.2 and linkage to the myotonic dystrophy locus. Genomics (1988) 1.55
Absence of genetic heterogeneity in Duchenne muscular dystrophy shown by a linkage study using two cloned DNA sequences. J Med Genet (1983) 1.54
Strategies to maintain the credibility of sham acupuncture used as a control treatment in clinical trials. J Altern Complement Med (1997) 1.53
Diagnostic criteria for scrub typhus: probability values for immunofluorescent antibody and Proteus OXK agglutinin titers. Am J Trop Med Hyg (1983) 1.51
Becker muscular dystrophy: correlation of deletion type with clinical severity. J Med Genet (1990) 1.50
Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disord (1997) 1.49
Mild form of Hunter's syndrome: clinical delineation based on 31 cases. Arch Dis Child (1982) 1.46
Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet (1999) 1.45
Congenital dystrophia myotonica. Neurology (1973) 1.45
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
Child-resistant containers really are effective. Lancet (1979) 1.43
Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Arch Dis Child (1979) 1.43
Factors predicting cesarean delivery for American Indian women in New Mexico. Birth (1999) 1.43
Genetic counselling in facioscapulohumeral muscular dystrophy. J Med Genet (1991) 1.42
General practitioners' prescribing data for multiple sclerosis patients indicates a link with asthma. Br J Gen Pract (2000) 1.41
Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation (2000) 1.41
Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis (2003) 1.41